ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MDWD MediWound Limited

16.31
0.27 (1.68%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
MediWound Limited NASDAQ:MDWD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.27 1.68% 16.31 16.23 17.25 16.89 15.84 16.27 38,686 21:30:00

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

31/05/2023 9:11pm

Edgar (US Regulatory)




SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C.  20549
______________________
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
 
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 
For the month of May 2023
 
Commission File Number: 001-36349
 
MediWound Ltd.
(Translation of registrant’s name into English)
 
42 Hayarkon Street
Yavne, 8122745 Israel
 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F  ☒         Form 40-F   ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   __
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   __
 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
 
On May 31, 2023, MediWound Ltd. (the “Company”) made available a corporate presentation on its website. A copy of the presentation is attached hereto as Exhibit 99.1. The fact that the presentation is being made available and furnished herewith is not an admission as to the materiality of any information contained in the presentation. The information contained in the presentation is being provided as of May 31, 2023 and the Company does not undertake any obligation to update the presentation in the future or to update forward-looking statements to reflect subsequent actual results.

2

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  MEDIWOUND LTD.  
       
Date: May 31, 2023
By:
/s/ Hani Luxenburg  
  Name: Hani Luxenburg  
  Title: Chief Financial Officer  

3

EXHIBIT INDEX

The following exhibit is filed as part of this Form 6-K:

Exhibit Description
 
 
99.1 Corporate presentation dated May 2023

4

1 Year MediWound Chart

1 Year MediWound Chart

1 Month MediWound Chart

1 Month MediWound Chart